Hoxton Ventures
VC Fund
London, United Kingdom
Hoxton Ventures is a VC fund in London focused on Artificial Intelligence and Software. Hoxton Ventures focuses on startups that either disrupt existing industries or invent entirely new market categories. Hoxton typically invests between $500,000 and $5 million into pre-seed, seed, and Series A stage companies, and follows its capital through the life of the company. The firm is based in London and invests all across Europe.
- Total investments:
- 141
- Last investment:
- Lead investor:
- 43%
- Fund size:
- $60M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Hoxton Ventures invests in
Stages Hoxton Ventures invests in
Countries Hoxton Ventures invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 9 contacts → | |||
Round size
- Seed
- $1.9M–$12M
- Series A
- $5M–$28M
- Series B
- $6M–$35M
Investment Focus
Industry
- Artificial Intelligence 22 (16%)
- Software 15 (11%)
- Health Care 15 (11%)
- Biotechnology 13 (9%)
- Information Technology 13 (9%)
Stage
- Seed 56 (40%)
- Series A 32 (23%)
- Series B 9 (6%)
- Pre-Seed 7 (5%)
- Venture - Series Unknown 7 (5%)
Country
- United Kingdom 49 (35%)
- United States 15 (11%)
- Canada 2 (1%)
- France 2 (1%)
- Romania 2 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Hussein Kanji
Partner
|
Partner | Total investments: 58 | Find email | |
Bryan Gartner
Partner
|
Partner | Total investments: 6 | Find email | |
|
Dahlia Jacobs
Finance Director
|
Finance Director | Total investments: 0 | Find email | |
Isabel Fox
Head of IR
|
Head of IR | Total investments: 6 | Find email | |
Mandeep Singh
Venture Partner
|
Venture Partner | Total investments: 87 | Find email | |
| See all 9 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Veridion provides private businesses with complete business data enrichment, including precise classification and real-time insights for market intelligence, insurance, procurement, and other areas. | $20M / Series A / Sep 16, 2026 | ||
| Eterna Regeneratives is a provider of a biomaterials platform for tissue regeneration. | $4M / Seed / Sep 16, 2026 | ||
| Behavox is an enterprise platform that unifies all types of data into a single data lake, allowing users to query the data and apply machine learning to identify capital markets misconduct and insider threats.Separate Behavox installations form the network defence that aggregates misconduct detection algorithms. The network then uses machinelearning and AI to optimise detection algorithms and suggest new ones. This innovation enables the “brains” to the system to continuously improve and evolve.Complex, high-load and sophisticated engineering is at the core of all the products that Behavox develops to enable deployment at the largest institutions in financial services. They are taking cutting-edge academic research and applying it to enterprise problems that require complex backend engineering with large-scale production footprint. | $173.2M / Private Equity / Jun 17, 2026 | ||
| Giraffe360 is game-changing subscription product for real estate companies to streamline professional quality photography and high accuracy floor plan creation. | $10M / Series B / Mar 26, 2026 | ||
| Preply is a provider of an online tutoring marketplace intended to promote faster learning with one-on-one online tutors. The company's marketplace helps to find and book professional private tutors online from over 185 countries, enabling users to achieve their goals and speak confidently. | $150M / Series D / Jan 21, 2026 | ||
| Smartline is a jewelry and a wearable technology company which develops products that seamlessly blend jewelry design and useful features | $461.6K / Venture - Series Unknown / Nov 19, 2025 | ||
| Valink Therapeutics is a health care drug discovery for next-generation cancer treatments. | $11.8M / Seed / Oct 20, 2025 | ||
| Milvus Advanced is a chemical company that develops cutting-edge nanoalloys as substitutes for high-value metals crucial to decarbonisation. | $6.9M / Seed / Oct 20, 2025 | ||
| Finster AI offers AI agents that can read, analyse and integrate disparate sources of financial and market data. | $10M / Series A / Oct 20, 2025 | ||
| Phagos Biotech addresses the looming pandemic of antibiotic resistance with bacteriophage solutions to efficiently address bacterial infections in seafood and livestock. | $29.1M / Series A / Oct 08, 2025 | ||
| See all 141 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Hoxton Ventures invest in?
Hoxton Ventures invests primarily in Artificial Intelligence, Software and Health Care startups, most often at Seed and Series A stage. Most of the 141 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Hoxton Ventures's check size?
Hoxton Ventures typically joins rounds of $1.9M–$12M at Seed, $5M–$28M at Series A and $6M–$35M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Hoxton Ventures participates in.
How do I contact Hoxton Ventures?
Public channels for Hoxton Ventures include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Hoxton Ventures?
The team at Hoxton Ventures includes Hussein Kanji (Partner), Bryan Gartner (Partner) and Dahlia Jacobs (Finance Director), among 9 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
